All articles tagged with #azelastine
Research suggests that an over-the-counter nasal spray containing azelastine may reduce the risk of COVID-19 and the common cold, with a phase 2 trial showing fewer infections among users, but more studies are needed before it can be recommended as a preventive measure alongside vaccines and other precautions.
A recent trial shows that over-the-counter azelastine nasal spray significantly reduces COVID-19 infection rates by two-thirds, suggesting it could be an effective, affordable, and easy-to-use preventive measure, especially for high-risk groups, though further research is needed before it can be widely recommended.
A recent randomized controlled trial suggests that azelastine nasal spray, an OTC medication, may significantly reduce the risk of COVID-19 infection by 67%, along with other respiratory viruses, though further research is needed to confirm these findings.
A study published in JAMA Internal Medicine found that azelastine, an over-the-counter antihistamine nasal spray, reduced COVID-19 infection risk by 69% in a clinical trial, suggesting potential as a prophylactic measure, especially during respiratory virus seasons.